Skip to main content
. 2019 Apr 19;48(1):1–10. doi: 10.1007/s11239-019-01860-7

Fig. 3.

Fig. 3

Bleeding events following de-escalation from ticagrelor to clopidogrel. a Any Bleeding (I2 = 90.8%); RE: Random Effects. b Major Bleeding (I2 = 0.00%); RE: Random Effects